Precision oncology startup 4baseCare has launched the second version of its comprehensive genomic profiling (CGP) test, TARGT Indiegene V2, expanding the panel to 2,206 genes as it looks to improve the detection of clinically relevant cancer biomarkers.The new version comes five years after the company launched Indiegene in August 2021. The original panel, developed using genomic data from Indian cancer patients, covered 1,212 genes and was
